The Weekly Litigation News Digest is now live. Subscribe now

IP Verse

Rb Pharmaceuticals competitive analysis

Loading summary...

Latest patents of Rb Pharmaceuticals opposed by its competitors

Explore Rb Pharmaceuticals's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Nov 13, 2025
Patent NumberPublication DateTitleTotal Oppositions
EP2579874
Jan 10, 2018Injectable Flowable Composition Comprising Buprenorphine1

Latest PTAB cases involving Rb Pharmaceuticals

Discover the latest PTAB cases involving Rb Pharmaceuticals, highlighting their recent legal challenges and patent disputes.

Last updated on: Nov 14, 2025
Proceeding NumberFiling DatePetitionerRespondentStatus

Get alerts for PTAB Cases involving Rb Pharmaceuticals

IPR2014-00998Jun 20, 2014BIODELIVERY SCIENCESRB PHARMACEUTICALSInstitution Denied
IPR2014-00325Jan 15, 2014BIODELIVERY SCIENCESRB PHARMACEUTICALSFinal Written Decision

Peer Comparison New

IP litigation analysis comparing Rb Pharmaceuticals with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Nov 13, 2025
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases Faced
RB PHARMACEUTICALS - 1 - 2
BIODELIVERY SCIENCES - - 9 -
TEVA PHARMACEUTICALS20916 - 12